BIOCRYST PHARMACEUTICALS INC - BCRX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | — | A | A | 33,540.0 | 0.0 | 0.0 | 33,540.0 | View | |
| Jun 15, 2026 | — | A | A | 15,294.0 | 0.0 | 0.0 | 31,938.0 | View | |
| Jun 15, 2026 | — | A | A | 33,540.0 | 0.0 | 0.0 | 33,540.0 | View | |
| Jun 15, 2026 | — | A | A | 15,294.0 | 0.0 | 0.0 | 27,794.0 | View | |
| Jun 15, 2026 | — | A | A | 33,540.0 | 0.0 | 0.0 | 33,540.0 | View | |
| Jun 15, 2026 | — | A | A | 15,294.0 | 0.0 | 0.0 | 79,565.0 | View | |
| Jun 15, 2026 | — | A | A | 33,540.0 | 0.0 | 0.0 | 33,540.0 | View | |
| Jun 15, 2026 | — | A | A | 15,294.0 | 0.0 | 0.0 | 35,459.0 | View | |
| Jun 15, 2026 | — | A | A | 33,540.0 | 0.0 | 0.0 | 33,540.0 | View | |
| Jun 15, 2026 | — | A | A | 15,294.0 | 0.0 | 0.0 | 45,936.0 | View | |
| Jun 15, 2026 | — | A | A | 33,540.0 | 0.0 | 0.0 | 33,540.0 | View | |
| Jun 15, 2026 | — | A | A | 15,294.0 | 0.0 | 0.0 | 108,483.0 | View | |
| Jun 15, 2026 | — | A | A | 33,540.0 | 0.0 | 0.0 | 33,540.0 | View | |
| Jun 15, 2026 | — | A | A | 15,294.0 | 0.0 | 0.0 | 1,339,775.0 | View | |
| Jun 15, 2026 | — | A | A | 33,540.0 | 0.0 | 0.0 | 33,540.0 | View | |
| Jun 15, 2026 | — | A | A | 15,294.0 | 0.0 | 0.0 | 47,177.0 | View | |
| Jun 15, 2026 | — | A | A | 33,540.0 | 0.0 | 0.0 | 33,540.0 | View | |
| Jun 15, 2026 | — | A | A | 15,294.0 | 0.0 | 0.0 | 80,646.0 | View | |
| Jun 02, 2026 | — | A | A | 1,262.0 | 8.91 | 11,244.42 | 16,644.0 | View | |
| Jun 02, 2026 | — | A | A | 631.0 | 8.91 | 5,622.21 | 1,324,481.0 | View | |
| Jun 02, 2026 | — | A | A | 631.0 | 8.91 | 5,622.21 | 31,883.0 | View | |
| Jun 02, 2026 | — | A | A | 1,122.0 | 8.91 | 9,997.02 | 93,189.0 | View | |
| Jun 02, 2026 | — | A | A | 1,262.0 | 8.91 | 11,244.42 | 20,165.0 | View | |
| May 19, 2026 | — | S | D | 11,180.0 | 8.97 | 100,284.6 | 31,252.0 | View | |
| May 15, 2026 | Chief Legal Officer | M | D | 62,500.0 | 0.0 | 0.0 | 0.0 | View | |
| May 15, 2026 | Chief Legal Officer | S | D | 62,500.0 | 9.54 | 596,250.0 | 400,703.0 | View | |
| May 15, 2026 | Chief Legal Officer | M | A | 62,500.0 | 5.04 | 315,000.0 | 463,203.0 | View | |
| Apr 07, 2026 | Chief R&D Officer | A | A | 441,350.0 | 0.0 | 0.0 | 441,350.0 | View | |
| Apr 07, 2026 | Chief R&D Officer | A | A | 205,150.0 | 0.0 | 0.0 | 205,150.0 | View | |
| Mar 24, 2026 | — | M | D | 49,933.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 24, 2026 | — | S | D | 49,933.0 | 10.11 | 504,822.63 | 65,352.0 | View | |
| Mar 24, 2026 | — | M | A | 49,933.0 | 6.3 | 314,577.9 | 115,285.0 | View | |
| Mar 18, 2026 | Chief Legal Officer | M | D | 150,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 18, 2026 | Chief Legal Officer | S | D | 150,000.0 | 9.15 | 1,372,500.0 | 400,703.0 | View | |
| Mar 18, 2026 | Chief Legal Officer | M | A | 150,000.0 | 5.51 | 826,500.0 | 550,703.0 | View | |
| Mar 03, 2026 | — | A | A | 642.0 | 8.75 | 5,617.5 | 42,432.0 | View | |
| Mar 03, 2026 | — | A | A | 1,285.0 | 8.75 | 11,243.75 | 18,903.0 | View | |
| Mar 03, 2026 | — | A | A | 848.0 | 8.75 | 7,420.0 | 92,067.0 | View | |
| Mar 03, 2026 | — | M | D | 305,995.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 03, 2026 | — | D | D | 305,995.0 | 8.64 | 2,643,796.8 | 1,323,850.0 | View | |
| Mar 03, 2026 | — | M | A | 305,995.0 | 3.22 | 985,303.9 | 1,629,845.0 | View | |
| Mar 03, 2026 | — | A | A | 421.0 | 8.75 | 3,683.75 | 1,323,850.0 | View | |
| Mar 03, 2026 | — | A | A | 528.0 | 8.75 | 4,620.0 | 15,382.0 | View | |
| Jan 27, 2026 | — | A | A | 26,684.0 | 0.0 | 0.0 | 26,684.0 | View | |
| Jan 27, 2026 | — | A | A | 12,272.0 | 0.0 | 0.0 | 14,854.0 | View | |
| Jan 27, 2026 | — | A | A | 2,582.0 | — | — | 2,582.0 | View |